These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 8861540)

  • 21. [Aluminum associated bone disease in patients undergoing long-term hemodialysis].
    Hino M; Yamamoto I; Shigeno C; Aoki J; Torizuka K; Iwamoto N; Yamazaki S; Fukuda T; Kondo M; Yamamoto N
    Nihon Naibunpi Gakkai Zasshi; 1986 Jun; 62(6):724-36. PubMed ID: 3758431
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 1-alpha-Hydroxyvitamin D3 derivatives in the treatment of renal bone diseases: justification and optimal modalities of administration.
    Fournier A; Morinière PH; Oprisiu R; Yverneau-Hardy P; Westeel PF; Mazouz H; el Esper N; Ghazali A; Boudailliez B
    Nephron; 1995; 71(3):254-83. PubMed ID: 8569975
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alterations in serum and urine parameters reflecting bone turnover in uremic patients during treatment with 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3.
    Mortensen BM; Gordeladze JO; Lyngdal PT; Aarseth HP; Gautvik KM
    Miner Electrolyte Metab; 1993; 19(2):78-85. PubMed ID: 8377728
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies the alterations of biochemical and mineral contents in bone tissue of mus musculus due to aluminum toxicity and the protective action of desferrioxamine and deferiprone by FTIR, ICP-OES, SEM and XRD techniques.
    Sivakumar S; Khatiwada CP; Sivasubramanian J
    Spectrochim Acta A Mol Biomol Spectrosc; 2014 May; 126():59-67. PubMed ID: 24583473
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 22-Oxacalcitriol ameliorates high-turnover bone and marked osteitis fibrosa in rats with slowly progressive nephritis.
    Hirata M; Katsumata K; Masaki T; Koike N; Endo K; Tsunemi K; Ohkawa H; Kurokawa K; Fukagawa M
    Kidney Int; 1999 Dec; 56(6):2040-7. PubMed ID: 10594779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PTH-stimulated adenylate cyclase activity and bone histomorphometry in iliac crest biopsies in the evaluation of uremic patients: a pilot study with the use of artificial intelligence.
    Jablonski G; Nordahl K; Halse J; Dahl E; Aksnes L; Gautvik KM; Gordeladze JO
    Miner Electrolyte Metab; 1993; 19(6):351-61. PubMed ID: 8164616
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduced deposition of aluminium in trabecular bone of uraemic rats treated with dihydroxylated vitamin D metabolites.
    Ittel TH; Hofstädter F; Gladziwa U; Sieberth HG
    Nephrol Dial Transplant; 1989; 4(11):957-65. PubMed ID: 2516887
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The causes, diagnosis and treatment of aluminum toxicity in patients with chronic renal failure undergoing dialysis].
    Wang G; Zhu P; Wang S
    Zhonghua Nei Ke Za Zhi; 1996 Jan; 35(1):36-40. PubMed ID: 9275645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnosis of aluminum-related bone disease and treatment of aluminum toxicity with deferoxamine.
    Coburn JW; Norris KC
    Semin Nephrol; 1986 Dec; 6(4 Suppl 1):12-21. PubMed ID: 3299588
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Histological classification of uremic bone disease and clinical significance of bone biopsy].
    Zhu JM; Alfrey AC; Huffer WE
    Zhonghua Nei Ke Za Zhi; 1993 Jul; 32(7):444-7. PubMed ID: 8275820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intermittent administration of parathyroid hormone (1-37) improves growth and bone mineral density in uremic rats.
    Schmitt CP; Hessing S; Oh J; Weber L; Ochlich P; Mehls O
    Kidney Int; 2000 Apr; 57(4):1484-92. PubMed ID: 10760084
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term administration of vitamin D3 metabolites alters PTH-responsive osteoblastic adenylate cyclase in rats.
    Mortensen B; Gordeladze JO; Aksnes L; Gautvik KM
    Calcif Tissue Int; 1990 May; 46(5):339-45. PubMed ID: 2159835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Bone histology and clinical diagnostic criteria in aluminum-induced bone disease].
    Zhu JM
    Zhonghua Nei Ke Za Zhi; 1992 Jul; 31(7):413-6, 414. PubMed ID: 1298595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deferoxamine-induced bone changes in haemodialysis patients: a histomorphometric study.
    Charhon SA; Chavassieux P; Boivin G; Parisien M; Chapuy MC; Traeger J; Meunier PJ
    Clin Sci (Lond); 1987 Aug; 73(2):227-34. PubMed ID: 3652627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnosis and treatment of aluminium bone disease.
    D'Haese PC; Couttenye MM; De Broe ME
    Nephrol Dial Transplant; 1996; 11 Suppl 3():74-9. PubMed ID: 8840316
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Digital radiography as an alternative method in the evaluation of bone density in uremic rats.
    Castro BBA; Carmo WB; Oliveira RSMF; Peters VM; Jorgetti V; Custodio MR; Sanders-Pinheiro H
    J Bras Nefrol; 2020 Mar; 42(1):8-17. PubMed ID: 31419270
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Uremic toxin and bone metabolism.
    Iwasaki Y; Yamato H; Nii-Kono T; Fujieda A; Uchida M; Hosokawa A; Motojima M; Fukagawa M
    J Bone Miner Metab; 2006; 24(2):172-5. PubMed ID: 16502128
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The desferrioxamine test predicts bone aluminium burden induced by A1(OH)3 in uraemic patients but not mild histological osteomalacia.
    Fournier A; Fohrer P; Leflon P; Moriniere P; Tolani M; Lambrey G; Demontis R; Sebert JL; Van Devyver F; Debroe M
    Proc Eur Dial Transplant Assoc Eur Ren Assoc; 1985; 21():371-6. PubMed ID: 3991525
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RANKL/OPG system regulation by endogenous PTH and PTH1R/ATF4 axis in bone: Implications for bone accrual and strength in growing rats with mild uremia.
    Znorko B; Pawlak D; Oksztulska-Kolanek E; Domaniewski T; Pryczynicz A; Roszczenko A; Rogalska J; Lipowicz P; Doroszko M; Brzoska MM; Pawlak K
    Cytokine; 2018 Jun; 106():19-28. PubMed ID: 29529595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.